Use of botulinum toxin type A to prevent widening of facial scars

Adel M Wilson1

  • 1Department of Plastic Surgery, Cairo University, Cairo, Egypt. dr_adel_wilson@yahoo.com

Abstract

Insights

Botulinum toxin injections can improve facial scar healing by temporarily paralyzing muscles, reducing tension on wounds. This method offers superior results compared to other treatments for conspicuous facial scarring.

Area of Science:

  • Plastic Surgery
  • Dermatology
  • Regenerative Medicine

Background:

  • Facial wounds perpendicular to Langer's lines often result in poor healing and noticeable scarring.
  • Previous treatments like corticosteroids and ultrasound have shown limited efficacy.
  • Muscle tension on healing wounds impedes collagen maturation, leading to undesirable scar formation.

Purpose of the Study:

  • To evaluate the efficacy of botulinum toxin in improving the outcomes of facial scar revision surgery.
  • To assess the impact of muscle paralysis on wound healing tension and scar quality.

Main Methods:

  • The study involved 40 patients with significant facial scarring.
  • Botulinum toxin was administered to induce temporary muscle paralysis during scar revision surgery.
  • This approach aimed to reduce tension on wound edges during the critical collagen maturation phase.

Main Results:

  • Objective and subjective assessments revealed a 90% improvement in scar outcomes.
  • The technique demonstrated effectiveness in both primate models and human subjects.
  • Results surpassed those achieved with existing treatment modalities for facial scarring.

Conclusions:

  • Simultaneous administration of botulinum toxin injections with facial scar revision surgery is a promising therapeutic option.
  • This approach effectively mitigates the negative effects of muscle pull on healing wounds.
  • The study supports offering botulinum toxin as a viable treatment for patients with unsightly facial scars.

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...